東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Insulin Regulation of Reverse Choles...

Lee, Samuel.

FindBook

Google Book

Amazon

博客來

Insulin Regulation of Reverse Cholesterol Transport.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Insulin Regulation of Reverse Cholesterol Transport./
作者:	Lee, Samuel.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
面頁冊數:	160 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-08, Section: B.
Contained By:	Dissertations Abstracts International80-08B.
標題:	Biology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13427056
ISBN:	9780438819221

Insulin Regulation of Reverse Cholesterol Transport.
Lee, Samuel.

Insulin Regulation of Reverse Cholesterol Transport. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 160 p.

Source: Dissertations Abstracts International, Volume: 80-08, Section: B.

Thesis (Ph.D.)--Columbia University, 2019.

This item must not be sold to any third party vendors.

Insulin resistance and type 2 diabetes are pathogenetically linked to increased risk of cardiovascular disease. While insulin resistance is defined by a dysregulation in hepatic insulin signaling, it is unclear how this impairment relates to the development of cardiovascular disease. Recently, there has been evidence showing that in insulin resistant individuals, cardiovascular disease is associated with a defect in reverse cholesterol transport-the cardioprotective process by which excess cholesterol is removed from the periphery, and returned to the liver for biliary excretion. Reverse cholesterol transport is facilitated by high-density lipoprotein (HDL) metabolism. Thus, malfunction in HDL turnover during reverse cholesterol transport may contribute to the buildup of atherosclerotic plaques, and subsequent cardiovascular disease in insulin resistant individuals. In this thesis, we seek to establish a better understanding of HDL metabolism and reverse cholesterol transport, as they relate to key transcription factors that mediate hepatic insulin signaling, namely the insulin-repressible forkhead transcription factors, FoxO1, FoxO3, and FoxO4 (FoxOs). We demonstrate that mice with liver-specific triple FoxO knockout (L-FoxO1,3,4) have increased HDL-cholesterol (HDL-C), associated with decreased expression of HDL-C clearance factors, scavenger receptor class B type I (SR-BI) and hepatic lipase, and defective selective uptake of HDL-cholesteryl ester by the liver. As such, we uncover a novel mechanism by which HDL-mediated reverse cholesterol transport to the liver is regulated by the hepatic insulin→FoxO signaling pathway.

ISBN: 9780438819221Subjects--Topical Terms:

522710
Biology.
Subjects--Index Terms:

Cholesterol

Insulin Regulation of Reverse Cholesterol Transport.
LDR:02878nmm a2200397 4500 001 2272356
005 20201105110029.5
008 220629s2019 ||||||||||||||||| ||eng d
020 $a 9780438819221
035 $a (MiAaPQ)AAI13427056
035 $a (MiAaPQ)columbia:15059
035 $a AAI13427056
040 $a MiAaPQ $c MiAaPQ
100 1 $a Lee, Samuel. $3 3547129
245 1 0 $a Insulin Regulation of Reverse Cholesterol Transport.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 160 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-08, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Haeusler, Rebecca A.
502 $a Thesis (Ph.D.)--Columbia University, 2019.
506 $a This item must not be sold to any third party vendors.
520 $a Insulin resistance and type 2 diabetes are pathogenetically linked to increased risk of cardiovascular disease. While insulin resistance is defined by a dysregulation in hepatic insulin signaling, it is unclear how this impairment relates to the development of cardiovascular disease. Recently, there has been evidence showing that in insulin resistant individuals, cardiovascular disease is associated with a defect in reverse cholesterol transport-the cardioprotective process by which excess cholesterol is removed from the periphery, and returned to the liver for biliary excretion. Reverse cholesterol transport is facilitated by high-density lipoprotein (HDL) metabolism. Thus, malfunction in HDL turnover during reverse cholesterol transport may contribute to the buildup of atherosclerotic plaques, and subsequent cardiovascular disease in insulin resistant individuals. In this thesis, we seek to establish a better understanding of HDL metabolism and reverse cholesterol transport, as they relate to key transcription factors that mediate hepatic insulin signaling, namely the insulin-repressible forkhead transcription factors, FoxO1, FoxO3, and FoxO4 (FoxOs). We demonstrate that mice with liver-specific triple FoxO knockout (L-FoxO1,3,4) have increased HDL-cholesterol (HDL-C), associated with decreased expression of HDL-C clearance factors, scavenger receptor class B type I (SR-BI) and hepatic lipase, and defective selective uptake of HDL-cholesteryl ester by the liver. As such, we uncover a novel mechanism by which HDL-mediated reverse cholesterol transport to the liver is regulated by the hepatic insulin→FoxO signaling pathway.
590 $a School code: 0054.
650 4 $a Biology. $3 522710
650 4 $a Nutrition. $3 517777
653 $a Cholesterol
653 $a FoxO
653 $a HDL
653 $a Insulin
653 $a Lipoprotein metabolism
653 $a Reverse cholesterol transport
690 $a 0306
690 $a 0570
710 2 $a Columbia University. $b Nutritional and Metabolic Biology. $3 1684898
773 0 $t Dissertations Abstracts International $g 80-08B.
790 $a 0054
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13427056